CN1864730A - A cancer-treating medicine - Google Patents
A cancer-treating medicine Download PDFInfo
- Publication number
- CN1864730A CN1864730A CNA2005100108144A CN200510010814A CN1864730A CN 1864730 A CN1864730 A CN 1864730A CN A2005100108144 A CNA2005100108144 A CN A2005100108144A CN 200510010814 A CN200510010814 A CN 200510010814A CN 1864730 A CN1864730 A CN 1864730A
- Authority
- CN
- China
- Prior art keywords
- cancer
- herba
- gram
- hunt
- moschus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention provides a medicament for treating cancer, which is a pure natural Chinese medicinal herb preparation with good effect for treating lung carcinoma, hepatic carcinoma, gastric carcinoma, restocarcinoma and breast cancer.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation, especially a kind of pure Chinese medicinal preparation for the treatment of cancer.
Background technology
Cancer is to be difficult to one of incurable disease of curing at present in the world.With regard to present medical level, the diagnosis of various cancers has not been problem, but treatment for cancer is difficulty very, owing to also do not develop the medicine that as broad-spectrum antibiotic, can generally kill cancerous cell now, so most of cancer patient is carried out excision earlier, and then kill cancerous cell by X-ray therapy or chemotherapy, but these two kinds of methods also can be killed the normal healthy cell when killing cancerous cell, cause cancer patient's resistance and immunity degradation.Be the side effect of avoiding radiotherapy, chemotherapy to bring, the therapy for treatment of cancer that then adopts Chinese and western medicine to combine that has, but it is all not obvious to produce effects.Though the curing cancer drug of Chu Shouing has multiplely in the market, all have stronger specific aim, and curative effect also is limited.Therefore, be necessary to develop new curing cancer drug, to satisfy cancer patient's demand.
Summary of the invention
The object of the present invention is to provide a kind of evident in efficacy, curing cancer drug of having no side effect.
The present invention realizes by following technical proposal: a kind of curing cancer drug is characterized in that being made by the raw material of following weight portion:
Herba Asari 0-8 part Rhizoma Paridis 0-8 part
Fructus Bruceae 0-5 part Herba Taraxaci 0-10 part
Herba Euphorbiae Helioscopiae 0-5 part Spica Prunellae 0-10 part
Radix Trichosanthis 0-15 part Mel 0-20 part
Rhizoma Dioscoreae Bulbiferae 4-8 part Pericarpium Papaveris 1-3 part
Borneolum Syntheticum 10-15 part Fructus Gleditsia 2-6 part
Herba Hedyotidis Diffusae 20-40 part Radix Et Rhizoma Rhei 3-6 part
Diffuse Coptosapelta Ephemerantha lonchophylla (Hook. F) Hunt et Sum-merh. [Ephemerantha fimbrate (Bl.) Hunt et Summerh. 40-60 part Dendrobium nobile 10-20 part
Moschus 0.03-0.06 part.
Wherein, Herba Asari nature and flavor hardship, temperature, circulation of qi promoting can help digestion.Rhizoma Paridis nature and flavor hardship, suffering are slightly cold, the dissipating blood stasis that can stop blooding, and anti-inflammation detumescence, pain relieving is good for the stomach.Rhizoma Dioscoreae Bulbiferae nature and flavor hardship, flat, energy dissipating phlegm and resolving masses, removing toxic substances and promoting subsidence of swelling, cooling blood for hemostasis.Pericarpium Papaveris nature and flavor acid, puckery, flat has relieving diarrhea with astringents, astringing lung-QI and relieving cough, analgesic effect.Borneolum Syntheticum nature and flavor suffering, hardship, be slightly cold the refreshment of to have one's ideas straightened out, clearing away heat to alleviate pain.Fructus Gleditsia nature and flavor suffering, one-tenth, temperature can be dispeled the wind by eliminating phlegm, mass dissipating and swelling eliminating, moistening dryness for relaxing bowels.Fructus Bruceae nature and flavor hardship, cold, energy heat-clearing and toxic substances removing, dysentery relieving.The Herba Taraxaci nature and flavor are sweet, bitter, cold, have heat-clearing and toxic substances removing, eliminating carbuncle eliminating stagnation, the effect that dampness removing is treating stranguria.Herba Euphorbiae Helioscopiae nature and flavor suffering, hardship, be slightly cold, can inducing diuresis to remove edema, the removing toxic substances eliminating stagnation can be treated hepatocarcinoma behind the compatibility.Sweet, the little hardship of Radix Trichosanthis nature and flavor has clearing away heat and promoting production of body fluid, clearing away lung-heat and moistening for dryness, and the effect of detumescence and apocenosis can be treated pulmonary carcinoma behind the compatibility.Spica Prunellae nature and flavor hardship, suffering, cold, can relieve inflammation or internal heat makes eye bright mass dissipating and swelling eliminating.Herba Hedyotidis Diffusae property mildly bitter flavor, sweet, cold has heat-clearing and toxic substances removing, the effect that dampness removing is treating stranguria.Moschus nature and flavor suffering, temperature have the refreshment of having one's ideas straightened out, the eliminating carbuncle effect of invigorating blood circulation.The Dendrobium nobile slightly sweet flavor is slightly cold, energy replenishing YIN and removing heat, reinforcing stomach reg fluid.Radix Et Rhizoma Rhei nature and flavor hardship, cold has heat and toxic materials clearing away, eliminating fire and detoxication, cooling blood for hemostasis, the effect that jaundice eliminating is treating stranguria.
Curing cancer drug provided by the invention makes by following method:
1, Rhizoma Paridis, Herba Asari, Moschus cleaned, behind the airing, made powder, Fructus Bruceae is directly used;
2, with all the other medical material decocting in water 30-60 minute, filter, remove slag, concentrate, concentrated solution;
3,1 step gained medicated powder is sneaked in the 2 step gained medicinal liquids, add Mel as required, behind the mix homogeneously, make preparations such as pharmaceutically acceptable tablet, capsule, pill, electuary.
The present invention has following advantage and effect: the curing cancer drug that adopts such scheme to make, has anti-inflammation detumescence, hemostasis and pain-relieving, the circulation of qi promoting that helps digestion, the spleen invigorating of being good for the stomach, preventing phlegm from forming and stopping coughing, clearing away heat and cooling blood, moistening dryness for relaxing bowels, detoxifcation dissipating blood stasis, sore-throat relieving lung moistening, multiple efficacies such as it is sensible to invigorate blood circulation, can effectively treat cancers such as pulmonary carcinoma, hepatocarcinoma, gastric cancer and breast carcinoma, colon cancer, rectal cancer, cure rate is higher, reaches more than 75%, taking convenience, having no side effect, can also improve body resistivity and immunity, is an ideal curing cancer drug in fact.
For showing curative effect of the present invention, now of the present invention 100 routine clinical observation result are reported as follows:
One, data and method
1, physical data
Cancer patient's 100 examples of making a definite diagnosis through hospital, wherein, patients with lung cancer 15 examples, manifest symptom is a dyspnea, cough band blood, the feed difficulty, sleep reduces; Liver cancer patient 20 examples, with the abdominal part enlargement, pain unbearably, appetite is few, sleep is few; Patients with gastric cancer 18 examples, manifest symptom are that stomachache is hard to bear, can not take food difficulty in walking; Rectal cancer 22 patient's examples, with the abdominal part enlargement, feed difficulty, sharp ache, stool band blood; Patient with breast cancer's 25 examples, breast has tangible lump, and pain unbearably, can not sleep peacefully walking disorder.Now with all kinds of case random packet, details see Table 1.
Two groups of patients' ordinary circumstance (n=100) is organized in table 1 matched group and treatment
| Project | Pulmonary carcinoma liver cancer treatment group (n=20) | (n=35) matched group (n=15) | Curing gastric cancer group (n=10) | (n=18) matched group (n=8) | Rectum cancer treatment group (n=12) | (n=22) matched group (n=10) | Breast cancer treatment group (n=16) | (n=25) contrast fine horse (n=9) |
| Sex masculinity femininity age 26--35 year 31--50 year is more than 51 years old | 12 8 3 9 8 | 10 5 2 5 8 | 5 5 2 3 5 | 3 5 1 3 5 | 8 4 2 5 5 | 4 6 1 5 4 | 16 3 8 5 | 9 1 5 3 |
Through X
2Check, two groups of ages, sex, characteristic of diseases all have comparability (p＞0.05)
2, Therapeutic Method
Matched group is taken commercially available anticancer tablet, three times on the one, one time six.
The treatment group is taken the present invention's pill or tablet, and three times on the one, each 2.0g all uses a small amount of warm water delivery service at every turn.
All take for two groups, and during treating, cut out other related drugs by identical 10 weeks of the course of treatment, and taboo temperature compensation food.
3, observational technique
Period in a medicine is observed weekly once, comprises symptom, sign improvement situation, untoward reaction.The pressure of having a blood test respectively before and after the treatment is looked into heart, liver, renal function and routine urinalysis.Treatment finishes to check the state of an illness to hospital in two weeks.
Two, curative effect judgment criteria
1, criterion of therapeutical effect
According to Ministry of Public Health bureau of drug administration about the clinical research guideline of cancer " new drug (Chinese medicine) treatment ", criterion of therapeutical effect.
Cure: cancerous cell reduces, and body immunity improves, and resistance strengthens, and is energetic, painless;
Produce effects: cancerous cell is effectively controlled, and immunity increases, no pain;
Effectively: cancerous cell is inhibited substantially, and immunity improves, and spirit is not good enough, pain relief;
Invalid: cancerous cell is constant, and inflammation is not eliminated, and mental status is poor, still has pain, and symptom is obvious.
2, statistical method
Enumeration data adopts X
2The t check is adopted in check, measurement data.
Total effective rate=cure rate+obvious effective rate+effective percentage
Three, result
1, pulmonary carcinoma hepatocarcinoma improvement situation sees Table 2.
Table 2, pulmonary carcinoma hepatocarcinoma are improved situation (35 example)
| Cure | Produce effects | Effectively | Invalid | Effective percentage | |
| 20 matched groups 15 are organized in treatment | 3 1 | 5 3 | 8 5 | 4 6 | 80.00％ 60.00％ |
Treatment group curative effect obviously is better than matched group (p＞0.01)
2, gastric cancer improvement situation sees Table 3.
Table 3, gastric cancer are improved situation (18 example)
| Cure | Produce effects | Effectively | Invalid | Effective percentage | |
| 10 matched groups 8 are organized in treatment | 3 1 | 2 1 | 3 3 | 2 3 | 80.00％ 62.50％ |
Treatment group curative effect obviously is better than matched group (p＞0.01)
3, rectal cancer improvement situation sees Table 4.
Table 4, rectal cancer improve situation (22 example)
| Cure | Produce effects | Effectively | Invalid | Effective percentage | |
| 12 matched groups 10 are organized in treatment | 3 1 | 3 2 | 4 3 | 2 4 | 73.33％ 60.00％ |
Treatment group curative effect obviously is better than matched group (p＞0.01)
4, breast carcinoma improvement situation sees Table 5.
Table 5, breast carcinoma are improved situation (25 example)
| Cure | Produce effects | Effectively | Invalid | Effective percentage | |
| 16 matched groups 9 are organized in treatment | 4 1 | 4 2 | 6 3 | 2 3 | 87.50％ 66.66％ |
Treatment group curative effect obviously is better than matched group (p＞0.01)
5, untoward reaction
Treatment group patient has no adverse reaction.The matched group patient has symptom in various degree such as xerostomia, scorching, constipation.
Four, discuss
The present invention is the pure natural Chinese herbal and crude drugs preparations, it is through research and the clinical observation of two more than ten years, in conjunction with the Chinese medicine theory,, be auxilliary mainly to attack to support, has liver-smoothing, qi-regulating, blood circulation promoting and blood stasis dispelling, clearing away heat and cooling blood, anti-inflammatory analgetic, the detumescence hemostasis, moistening dryness for relaxing bowels, it is sensible to detoxify, effects such as sore-throat relieving lung moistening, and have no side effect, to pulmonary carcinoma, hepatocarcinoma, gastric cancer, rectal cancer, multiple cancer such as breast carcinoma has better therapeutic effect, cooperates postoperative treatment more favourable, compared with similar products, this medicine can shorten the course of treatment significantly, and instant effect, total effective rate reach more than 80%, extremely local patient's favorable comment, therefore, be one and have the cancer treatment drugs that exploitation is worth.
The specific embodiment
Below in conjunction with embodiment the present invention is described further.
Embodiment 1
Get material by following prescription:
Rhizoma Dioscoreae Bulbiferae 8 gram Pericarpium Papaveriss 3 grams
Borneolum Syntheticum 10 gram Fructus Gleditsias 6 grams
Fructus Bruceae 3 gram Herba Euphorbiae Helioscopiae 5 grams
Spica Prunellae 10 gram Radix Et Rhizoma Rhei 3 grams
Herba Hedyotidis Diffusae 20 gram Moschus 0.04 gram
Dendrobium nobile 10 gram Diffuse Coptosapelta Ephemerantha lonchophylla (Hook. F) Hunt et Sum-merh. [Ephemerantha fimbrate (Bl.) Hunt et Summerh.s 50 grams
By following method:
1, except that Moschus, all the other medical materials were added decocting in water 30 minutes, filter, remove slag, concentrate, get concentrated solution;
2, Moschus is sneaked in the step 1 gained medicinal liquid, behind the mix homogeneously, make the pill of treatment hepatocarcinoma.
Embodiment 2
Get material by following prescription:
Rhizoma Dioscoreae Bulbiferae 4 gram Pericarpium Papaveriss 2 grams
Borneolum Syntheticum 15 gram Fructus Gleditsias 4 grams
Herba Hedyotidis Diffusae 40 gram Moschus 0.06 gram
Dendrobium nobile 20 gram Radix Et Rhizoma Rhei 3 grams
Diffuse Coptosapelta Ephemerantha lonchophylla (Hook. F) Hunt et Sum-merh. [Ephemerantha fimbrate (Bl.) Hunt et Summerh. 60 grams
Make the tablet of treatment pulmonary carcinoma by the method for embodiment 1.
Embodiment 3
Get material by following prescription:
Herba Asari the 8th grammes per square metre buildings 8 grams
Rhizoma Dioscoreae Bulbiferae 6 gram Pericarpium Papaveriss 2 grams
Borneolum Syntheticum 10 gram Fructus Gleditsias 4 grams
Herba Hedyotidis Diffusae 30 gram Moschus 0.03 gram
Dendrobium nobile 15 gram Radix Et Rhizoma Rhei 3 grams
Mel 20 gram Fructus Bruceaes 2 grams
Diffuse Coptosapelta Ephemerantha lonchophylla (Hook. F) Hunt et Sum-merh. [Ephemerantha fimbrate (Bl.) Hunt et Summerh. 40 grams
By following method
1, Rhizoma Paridis, Herba Asari, Moschus cleaned, behind the airing, made powder, Fructus Bruceae is directly used;
2, with all the other medical material decocting in water 60 minutes, filter, remove slag, concentrate, concentrated solution;
3,1 step gained medicated powder is sneaked in the 2 step gained medicinal liquids, add Mel, behind the mix homogeneously, make the capsule of treatment gastric cancer.
Embodiment 4
Get material by following prescription:
Rhizoma Dioscoreae Bulbiferae 6 gram Pericarpium Papaveriss 2 grams
Borneolum Syntheticum 12 gram Fructus Gleditsias 6 grams
Herba Hedyotidis Diffusae 25 gram Moschus 0.05 gram
Dendrobium nobile 20 gram Radix Et Rhizoma Rhei 6 grams
Diffuse Coptosapelta Ephemerantha lonchophylla (Hook. F) Hunt et Sum-merh. [Ephemerantha fimbrate (Bl.) Hunt et Summerh. 55 grams
Make the electuary of treatment rectal cancer by the method for embodiment 1.
Embodiment 5
Get material by following prescription:
Rhizoma Dioscoreae Bulbiferae 3 gram Pericarpium Papaveriss 1 gram
Borneolum Syntheticum 12 gram Fructus Gleditsias 3 grams
Herba Taraxaci 10 gram Moschus 0.03 gram
Radix Trichosanthis 10 gram Herba Hedyotidis Diffusaes 35 grams
Dendrobium nobile 30 gram Radix Et Rhizoma Rhei 4 grams
Diffuse Coptosapelta Ephemerantha lonchophylla (Hook. F) Hunt et Sum-merh. [Ephemerantha fimbrate (Bl.) Hunt et Summerh. 45 grams
Make the tablet of treatment breast carcinoma by the method for embodiment 1.
Claims (2)
1, a kind of curing cancer drug is characterized in that being made by the raw material of following weight portion:
Herba Asari 0-8 part Rhizoma Paridis 0-8 part
Fructus Bruceae 0-5 part Herba Taraxaci 0-10 part
Herba Euphorbiae Helioscopiae 0-5 part Spica Prunellae 0-10 part
Radix Trichosanthis 0-15 part Mel 0-20 part
Rhizoma Dioscoreae Bulbiferae 4-8 part Pericarpium Papaveris 1-3 part
Borneolum Syntheticum 10-15 part Fructus Gleditsia 2-6 part
Herba Hedyotidis Diffusae 20-40 part Radix Et Rhizoma Rhei 3-6 part
Diffuse Coptosapelta Ephemerantha lonchophylla (Hook. F) Hunt et Sum-merh. [Ephemerantha fimbrate (Bl.) Hunt et Summerh. 40-60 part Dendrobium nobile 10-20 part
Moschus 0.03-0.06 part.
2, curing cancer drug according to claim 1 is characterized in that by following method:
A, Rhizoma Paridis, Herba Asari, Moschus are cleaned, behind the airing, made powder, Fructus Bruceae is directly used;
B, with all the other medical material decocting in water 60 minutes, filter, remove slag, concentrate, concentrated solution;
C, 1 step gained medicated powder is sneaked in the 2 step gained medicinal liquids, add Mel, behind the mix homogeneously, make the capsule of treatment gastric cancer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100108144A CN100411668C (en) | 2005-05-20 | 2005-05-20 | A cancer-treating medicine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100108144A CN100411668C (en) | 2005-05-20 | 2005-05-20 | A cancer-treating medicine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1864730A true CN1864730A (en) | 2006-11-22 |
| CN100411668C CN100411668C (en) | 2008-08-20 |
Family
ID=37423982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100108144A Expired - Fee Related CN100411668C (en) | 2005-05-20 | 2005-05-20 | A cancer-treating medicine |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100411668C (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102727854A (en) * | 2012-07-05 | 2012-10-17 | 许瑞琴 | Traditional Chinese medicine for treatment of gastric cancer |
| CN103393743A (en) * | 2013-07-10 | 2013-11-20 | 聂纪强 | Traditional Chinese medicine composite for treating tumor |
| WO2013185298A1 (en) * | 2012-06-12 | 2013-12-19 | Nie Pingsheng | Chinese medicine for treating breast cancer |
| CN104288405A (en) * | 2014-11-04 | 2015-01-21 | 赵虹 | Preparation method of assisted drug for postoperative chemo-treatment of non-small cell lung cancer |
| CN104288404A (en) * | 2014-11-04 | 2015-01-21 | 赵虹 | Assisted drug for postoperative chemo-treatment of non-small cell lung cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1251756C (en) * | 2001-12-04 | 2006-04-19 | 何文法 | Series Chinese medicinal composition for treating tumor |
| CN1205960C (en) * | 2002-12-13 | 2005-06-15 | 济南市第四人民医院 | Auxiliary medicine for treating esophagus cancer and processing method thereof |
-
2005
- 2005-05-20 CN CNB2005100108144A patent/CN100411668C/en not_active Expired - Fee Related
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013185298A1 (en) * | 2012-06-12 | 2013-12-19 | Nie Pingsheng | Chinese medicine for treating breast cancer |
| CN102727854A (en) * | 2012-07-05 | 2012-10-17 | 许瑞琴 | Traditional Chinese medicine for treatment of gastric cancer |
| CN102727854B (en) * | 2012-07-05 | 2013-08-28 | 许瑞琴 | Traditional Chinese medicine for treatment of gastric cancer |
| CN103393743A (en) * | 2013-07-10 | 2013-11-20 | 聂纪强 | Traditional Chinese medicine composite for treating tumor |
| CN103393743B (en) * | 2013-07-10 | 2015-12-23 | 聂纪强 | A kind of Chinese medicine composition for the treatment of tumor |
| CN104288405A (en) * | 2014-11-04 | 2015-01-21 | 赵虹 | Preparation method of assisted drug for postoperative chemo-treatment of non-small cell lung cancer |
| CN104288404A (en) * | 2014-11-04 | 2015-01-21 | 赵虹 | Assisted drug for postoperative chemo-treatment of non-small cell lung cancer |
| CN104288404B (en) * | 2014-11-04 | 2018-04-27 | 刘新刚 | A kind of ancillary drug for non-small cell lung cancer postoperative chemotherapy |
| CN104288405B (en) * | 2014-11-04 | 2018-10-16 | 日照轩宜信息科技有限公司 | A kind of preparation method for non-small cell lung cancer postoperative chemotherapy ancillary drug |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100411668C (en) | 2008-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1836720A (en) | Chinese medicine composition for treating arthritis or gout and preparing method thereof | |
| CN1305513C (en) | Broad-spectrum cancer-treating Chinese medicine prepn and its prepn process | |
| CN1879857A (en) | Medicinal powder for treating mammary gland disease | |
| CN1864730A (en) | A cancer-treating medicine | |
| CN1299745C (en) | Medicament composition for treating tumour | |
| CN1270746C (en) | Medicine for diminishing the inflammation and reducing the pain, subsiding swelling to dissipate indurated mass, dredging meridian to removing stagnation | |
| CN1861184A (en) | Application of composition for preparing medicine to treat chilblain disease | |
| CN100531791C (en) | Antineoplastic, anti-cancer drugs | |
| CN1772257A (en) | Fatty liver treating notoginseng prepn and its prepn process | |
| CN1205993C (en) | Huaaidan pellet medicine for treating cancer and preparation method thereof | |
| CN1465387A (en) | Chinese medicine preparation for treating carcinoma of esophagus | |
| CN1191849C (en) | Chinese medicine for treating breast disease | |
| CN101032540A (en) | Medicine composition for curing arthritis and the preparing method and purpose thereof | |
| CN1843441A (en) | Rheumatism-eliminating collaterals-dredging externally applied plaster | |
| CN1140071A (en) | Anticancer drug and preparing method thereof | |
| CN1304045C (en) | Arthralgia removing pills and their preparation | |
| CN1686497A (en) | Chinese medicinal preparation for treating sexual dysfunction, menoxenia, aciesis and developing immunity | |
| CN1471954A (en) | Chinese medicine for withdrawal of drug dependence | |
| CN101584802B (en) | Chinese medicinal capsule for treating malignant lymphoma | |
| CN1256976C (en) | Anti-cancer Chinese medicinal composition and its preparing method | |
| CN1304027C (en) | Bone nourishing and rheumatic treating pills and their preparation | |
| CN100344301C (en) | Orally medicine for treating vitiligo and production method thereof | |
| CN1304043C (en) | Longhedan pills and their preparation | |
| CN1891281A (en) | Chinese medicine preparation for treating wind-cold disease, and its preparing method | |
| CN1720937A (en) | Capsule for treating rheumatism and rheumatoid diseases and scapulohumeral periarthritis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080820 Termination date: 20170520 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |